MedTrace Logo

The Coronary AccEss After Tavi Registry - A Multicenter Prospective Registry for the Coronary Access After TAVI

NCT04647864 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2021-07-16

No results posted yet for this study

Summary

The CAvEAT study is a not for profit, international, multicenter study aimed to assess the feasibility of selective coronary angiography (CA) after Transcatheter Aortic Valve Implantation (TAVI), to investigate predictors of successful selective cannulation (anatomical, technical, etc.) and to investigate if there is a significant difference among different type of transcatheter valves in selective coronary cannulation.

Conditions

  • Aortic Valve Disease

Interventions

DEVICE

Transcatheter Aortic Valve Implantation

Replacement of the aortic valve of the heart through the blood vessels, delivered via one of several access methods.

Sponsors & Collaborators

  • Fondazione GISE Onlus

    collaborator OTHER

  • University of Padova

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-28
Primary Completion
2022-06-01
Completion
2022-12-01
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04647864 on ClinicalTrials.gov